Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profileg
Vinay Prasad MD MPH

@VPrasadMDMPH

Prof @ucsf, Physician-Scientist, IG @vprasadmdmph @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views mine

ID:1194962714

linkhttp://www.drvinayprasad.com calendar_today18-02-2013 21:24:10

45,1K Tweets

286,9K Followers

3,8K Following

John Mandrola, MD(@drjohnm) 's Twitter Profile Photo

I’m not an oncologist and a lot these studies are intimidating due to the hard names of drugs. But. If I’m diagnosed with cancer, and a doc recommends a Rx, I’m googling it along with “Vinay Prasad”. Incredibly important work for patients and society. Kudos John Arnold

account_circle
Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profile Photo

Everything you need to know about Sotorasib
Will interest anyone interested in drug development
Consider subscribing for more
developdrugs.substack.com/p/sotorasib-kr…

Everything you need to know about Sotorasib Will interest anyone interested in drug development Consider subscribing for more developdrugs.substack.com/p/sotorasib-kr…
account_circle
Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profile Photo

Just out in the Drug Development Letter, I summarize arguments in the two papers on Sotorasib One by
Timothée Olivier, MD
and the other by Tito Fojo
Dr Amol Akhade
developdrugs.substack.com/p/sotorasib-kr…

Just out in the Drug Development Letter, I summarize arguments in the two papers on Sotorasib One by @Timothee_MD and the other by Tito Fojo @SuyogCancer developdrugs.substack.com/p/sotorasib-kr…
account_circle
Ash Paul(@pash22) 's Twitter Profile Photo

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials onlinelibrary.wiley.com/doi/10.1002/ca… via Vinay Prasad MD MPH et al

Assessing patient risk, benefit, and outcomes in drug development: A decade of ramucirumab clinical trials onlinelibrary.wiley.com/doi/10.1002/ca… via @VPrasadMDMPH et al
account_circle
Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profile Photo

Time 100 Health Care is a deeply problematic list
I go through specific examples where nominees embodied the opposite of what they are lauded for
Walid Gellad
Jay Bhattacharya Martin Kulldorff Marty Makary MD, MPH

open.substack.com/pub/vinayprasa…

account_circle
Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profile Photo

Drug makers make so much money from such marginal drugs, they are now incentivized to run portfolios of low value trials

This misuses patient participants and results in unacceptable harms

IRBs should become stronger
drive.google.com/file/d/10w7Gvs…

Drug makers make so much money from such marginal drugs, they are now incentivized to run portfolios of low value trials This misuses patient participants and results in unacceptable harms IRBs should become stronger drive.google.com/file/d/10w7Gvs…
account_circle
Vinay Prasad MD MPH(@VPrasadMDMPH) 's Twitter Profile Photo

What does it say about the US cancer system that a drug that only improves survival 1.5 months in 3 tumor types can be given to 10,000 research participants, in many cases, based on a lark

The conclusion is....

What does it say about the US cancer system that a drug that only improves survival 1.5 months in 3 tumor types can be given to 10,000 research participants, in many cases, based on a lark The conclusion is....
account_circle
Econlib(@Econlib) 's Twitter Profile Photo

Two episodes about economics, two more about Israel. One about affirmative action and another about dying well. Anything related to health researcher Vinay Prasad and blogger @TylerCowen: @econtalker shares the surprising list of fav episodes from 2023: ow.ly/MI4O50RqKui

account_circle